Literature DB >> 25148591

Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments.

Christian Jöst1, Christoph Nitsche, Therese Scholz, Lionel Roux, Christian D Klein.   

Abstract

Covalent ligand-target interactions offer significant pharmacological advantages. However, off-target reactivity of the reactive groups, which usually have electrophilic properties, must be minimized, and the selectivity of irreversible inhibitors is a crucial requirement. We therefore performed a systematic study to determine the selectivity of several electrophilic groups that can be used as building blocks for covalently binding ligands. Six reactive groups with modulated electrophilicity were combined with 11 nonreactive moieties, resulting in a small combinatorial library of 72 fragment-like compounds. These compounds were screened against a group of 11 enzyme targets to assess their selectivity and their potential for promiscuous binding to proteins. The assay results showed a considerably lower degree of promiscuity than initially expected, even for those members of the screening collection that contain supposedly highly reactive electrophiles.

Mesh:

Substances:

Year:  2014        PMID: 25148591     DOI: 10.1021/jm5006918

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  28 in total

1.  Generating enzyme and radical-mediated bisubstrates as tools for investigating Gcn5-related N-acetyltransferases.

Authors:  Cory Reidl; Karolina A Majorek; Joseph Dang; David Tran; Kristen Jew; Melissa Law; Yasmine Payne; Wladek Minor; Daniel P Becker; Misty L Kuhn
Journal:  FEBS Lett       Date:  2017-08-01       Impact factor: 4.124

Review 2.  Covalent modification of biological targets with natural products through Paal-Knorr pyrrole formation.

Authors:  Alexander Kornienko; James J La Clair
Journal:  Nat Prod Rep       Date:  2017-08-30       Impact factor: 13.423

Review 3.  Counting on natural products for drug design.

Authors:  Tiago Rodrigues; Daniel Reker; Petra Schneider; Gisbert Schneider
Journal:  Nat Chem       Date:  2016-04-25       Impact factor: 24.427

Review 4.  Mechanistic enzymology in drug discovery: a fresh perspective.

Authors:  Geoffrey A Holdgate; Thomas D Meek; Rachel L Grimley
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

5.  Using Protein-Confined Proximity To Determine Chemical Reactivity.

Authors:  Tomonori Kobayashi; Christian Hoppmann; Bing Yang; Lei Wang
Journal:  J Am Chem Soc       Date:  2016-11-04       Impact factor: 15.419

6.  Characterizing the Covalent Targets of a Small Molecule Inhibitor of the Lysine Acetyltransferase P300.

Authors:  Jonathan H Shrimp; Alexander W Sorum; Julie M Garlick; Laura Guasch; Marc C Nicklaus; Jordan L Meier
Journal:  ACS Med Chem Lett       Date:  2015-10-31       Impact factor: 4.345

7.  ALARM NMR for HTS triage and chemical probe validation.

Authors:  Jayme L Dahlin; Matthew Cuellar; Gurpreet Singh; Kathryn M Nelson; Jessica Strasser; Todd Rappe; Youlin Xia; Gianluigi Veglia; Michael A Walters
Journal:  Curr Protoc Chem Biol       Date:  2018-04-09

8.  The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.

Authors:  Ahmed T Negmeldin; Joseph R Knoff; Mary Kay H Pflum
Journal:  Eur J Med Chem       Date:  2017-10-31       Impact factor: 6.514

9.  Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer.

Authors:  Liron Bar-Peled; Esther K Kemper; Radu M Suciu; Ekaterina V Vinogradova; Keriann M Backus; Benjamin D Horning; Thomas A Paul; Taka-Aki Ichu; Robert U Svensson; Jose Olucha; Max W Chang; Bernard P Kok; Zhou Zhu; Nathan T Ihle; Melissa M Dix; Ping Jiang; Matthew M Hayward; Enrique Saez; Reuben J Shaw; Benjamin F Cravatt
Journal:  Cell       Date:  2017-09-28       Impact factor: 41.582

10.  Targeted covalent inhibition of O-GlcNAc transferase in cells.

Authors:  Matthew Worth; Chia-Wei Hu; Hao Li; Dacheng Fan; Arielis Estevez; Dongsheng Zhu; Ao Wang; Jiaoyang Jiang
Journal:  Chem Commun (Camb)       Date:  2019-10-31       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.